New consortium partner to support clinical study

Universitätsklinikum Heidelberg joined SafePolyMed as an additional clinical partner retroactively as of 1 January 2025. Julia Stingl and Hanna Seidling lead Heidelberg's contributions to the project. With this new partner, a second German clinical site was added, increasing the number of clinical sites for the EmPaSafe study to a total of five. Thus, the consortium hopes to support the recruitment of German patients in this multinational study now taking place in Leiden, Patras, Ljubljana, Aachen and Heidelberg.